Iraq vs Lithuania: Previously treated cases tested for RR-/MDR-TB
Iraq
100.0%
in 2024
Lithuania
100.0%
in 2024
Iraq rank
1st
Lithuania rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Iraq
- Lithuania
How they compare
Iraq currently reports 100.0% against 100.0% in Lithuania, a difference of 0.0%.
Across all 18 years both countries report, Lithuania has been ahead every year.
Iraq ranks 1st and Lithuania ranks 1st of 180 countries.
Lithuania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iraq | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.7% | 100.0% | 82.3% | Lithuania |
| 2010s | 59.4% | 100.0% | 40.6% | Lithuania |
| 2020s | 97.6% | 100.0% | 2.4% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Iraq or Lithuania?
- Iraq, at 100.0% against 100.0% in Lithuania as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Iraq and Lithuania?
- 0.0%, with Iraq ahead.
- How many years of comparable data are there for Iraq and Lithuania?
- 18 years are reported by both, from 2007 to 2024.
- How do Iraq and Lithuania rank globally for previously treated cases tested for rr-/mdr-tb?
- Iraq ranks 1st and Lithuania ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.